Posts with tag: innovation
Novo Nordisk CEO is unconcerned about Medicare drug price negotiations due to comparable prices in Europe, previous experience, and the company's focus on a strong pipeline and next-generation drugs.
Published on: February 05, 2025, 08:02 PM UTC
Match Group shares plunge 10.2% premarket after weak Q4 results and missed guidance, casting doubt on management's ability to stabilize demand and subscriber trends.
Published on: February 05, 2025, 07:06 PM UTC
Workday (WDAY) stock surges 6.5% premarket on strong Q4 guidance and restructuring plans. Read our full analysis report for insights on the market's reaction and the stock's potential.
Published on: February 05, 2025, 07:05 PM UTC
Griffon Corp (GFF) shares jumped 10.7% after the consumer and professional products manufacturer reported Q4 results that beat EPS and EBITDA estimates but slightly missed on revenue.
Published on: February 05, 2025, 07:05 PM UTC
China has launched a dispute at the WTO over tariffs imposed by US President Donald Trump on Chinese goods. China says the measures are inconsistent with US obligations under the WTO agreement and reserves the right to take further action.
Published on: February 05, 2025, 07:05 PM UTC
Apple shares fell after a report that China is considering an antitrust probe into its App Store policies. The company has been facing regulatory scrutiny in the US and EU as well.
Published on: February 05, 2025, 07:03 PM UTC
Disney aims for streaming growth despite Netflix dominance, with 125 million Disney+ subscribers and plans for more content and paid sharing.
Published on: February 05, 2025, 07:03 PM UTC
Bond traders can exploit uncertainty caused by President Trump's policies to generate strong returns, according to Pacific Investment Management Co.'s chief investment officer. The asset manager is betting on five- to 10-year bonds, as they generate solid income, and are prepared to buy more if yields rise back toward 5%.
Published on: February 05, 2025, 07:01 PM UTC
Arm Holdings' valuation remains high despite AI concerns, with the stock up almost 40% in 2025. Investors will seek reassurance with upcoming earnings report amidst uncertainty in the AI landscape.
Published on: February 05, 2025, 07:01 PM UTC
Novo Nordisk's Q4 earnings beat expectations, with key semaglutide drugs driving growth. Despite expected slower growth in 2025, the company remains optimistic and is addressing headwinds like drug pricing negotiations and supply chain issues.
Published on: February 05, 2025, 06:03 PM UTC